ONCY
Oncolytics Biotech Inc
NASDAQ: ONCY · HEALTHCARE · BIOTECHNOLOGY
$0.88
+1.03% today
Updated 2026-04-30
Market cap
$112.49M
P/E ratio
—
P/S ratio
58.60x
EPS (TTM)
$-0.30
Dividend yield
—
52W range
$0 – $2
Volume
1.1M
Oncolytics Biotech Inc (ONCY) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+19.0%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.2%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-8.4%
2025-11-13
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-05 | $0.00 | +100.0% | $1.06 | $1.06 | +0.0% |
| 2025-11-13 | $-0.14 | -56.1% | $1.14 | $1.04 | -8.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.08 | $0.00 | +100.0% | — | — |
| 2025-09-30 | $-0.09 | $-0.14 | -56.1% | — | — |
| 2025-06-30 | $-0.09 | $-0.07 | +20.9% | — | — |
| 2025-03-31 | $-0.09 | $-0.08 | +11.1% | — | — |
| 2024-12-31 | $-0.13 | $-0.10 | +25.7% | — | — |
| 2024-09-30 | $-0.07 | $-0.09 | -29.7% | — | — |
| 2024-06-30 | $-0.10 | $-0.10 | +0.0% | — | — |
| 2024-03-31 | $-0.11 | $-0.09 | +18.2% | — | — |
| 2023-12-31 | $-0.15 | $-0.05 | +66.7% | — | — |
| 2023-09-30 | $-0.10 | $-0.14 | -40.0% | — | — |
| 2023-06-30 | $-0.11 | $-0.12 | -9.1% | — | — |
| 2023-03-31 | $-0.13 | $-0.10 | +23.1% | — | — |
Frequently asked questions
Has Oncolytics Biotech Inc beaten earnings estimates?
Oncolytics Biotech Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +19.0% over the last 4 quarters.
How does ONCY stock react to earnings?
ONCY stock has moved an average of -4.2% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.